Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ICON PLC (ICLR) vs QIAGEN N.V. (QGEN)

ICON PLC and QIAGEN N.V. are both Diagnostics & Research companies. ICON PLC is the larger, with a market value of $13.4B against $9.3B — 1.4× the size. QIAGEN N.V. trades at the lower P/E: 22.6× against 257×. ICON PLC grew revenue faster over the last twelve months: 3.26% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 0.51%) and the higher return on invested capital (6.62% vs 1.57%). Across the 22 metrics below, QIAGEN N.V. leads on 14 and ICON PLC on 8.

Valuation

Metric ICLR QGEN Diagnostics & Research median
P/E 257.44 22.64 33.95
P/S 1.60 4.34 4.87
P/B 1.41 2.72 3.12
Price to free cash flow 14.98 20.69 34.02
EV/EBITDA 23.55 15.31 25.20
EV/Sales 1.89 4.75 5.66
Earnings yield 0.39% 4.42% (1.75%)
Free cash flow yield 6.67% 4.83% (0.13%)

Profitability

Metric ICLR QGEN Diagnostics & Research median
Gross margin 23.91% 62.20% 50.89%
Operating margin 3.57% 21.21% (8.57%)
Net margin 0.51% 19.49% (6.37%)
Free cash flow margin 10.66% 20.98% 0.00%
Return on equity 0.45% 11.93% (2.92%)
Return on assets 0.26% 6.99% (6.71%)
Return on invested capital 1.57% 6.62% 0.00%

Growth

Metric ICLR QGEN Diagnostics & Research median
Revenue growth (TTM) 3.26% 2.96% 7.69%
EPS growth (last fiscal year) (69.57%) 398.07% —
Revenue growth, 5-year CAGR 24.15% 2.25% 7.40%
Net income growth, 5-year CAGR (7.15%) 3.42% 0.00%

Health

Metric ICLR QGEN Diagnostics & Research median
Debt to equity 0.36 0.49 0.11
Current ratio 0.95 2.85 2.02
Net debt to EBITDA 3.34 0.84 0.78

Dividend

Metric ICLR QGEN Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ICLR QGEN Diagnostics & Research median
Market cap 13.42b 9.26b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack